Mylagia P 500mcg/150mg Tablet
By Mylagia P
Rx
10 Tablet in a Strip

Composition
Methylcobalamin(500mcg) + Pregabalin(150mg)

Manufacturer - Medok Life Sciences Pvt Ltd
No. 2263/2, MW Town, Manimajra, Manimajra, Chandigarh-160017, India

Expires on or after
October, 2025

liver
Mylagia P 500mcg/150mg Tablet is considered safe for individuals with liver disease based on the available data. It appears that adjusting the dosage of Mylagia P 500mcg/150mg Tablet may not be necessary for these patients. It is essential to speak with your doctor for personalized guidance.

kidney
Mylagia P 500mcg/150mg Tablet should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor for proper guidance.

alcohol
When consuming alcohol with Mylagia P 500mcg/150mg Tablet, there may be increased drowsiness.

driving
Caution - Driving Mylagia P 500mcg/150mg Tablet may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Mylagia P 500mcg/150mg Tablet may be harmful during pregnancy. Animal studies indicate possible harm to the baby. Your doctor will assess benefits versus risks. Consult your doctor before using.

breastfeeding
Caution is advised while breastfeeding if considering the use of Mylagia P 500mcg/150mg Tablet, as it may be unsafe and could potentially harm the baby. Limited data suggests that the drug might pass into breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹110
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025